January 14th, 2008

SpeculatingStocks.com Stock Pick: Idenix Pharmaceuticals, Inc. (IDIX)

Stock Price: $4.29

Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of human viral and other infectious diseases in the United States and Europe. It primarily focuses on diseases caused by hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

IDIX was recently in the news over its telbivudine drug, produced jointly with Novartis AG. The drug showed promise for those with Hepatitis B. Compared to a competitor's drug, Telbivudine reduced the Hepatitis B virus more quickly and after 52 weeks, those taking telbivudine achieved 10 times more reduction of the virus per milliliter of blood.

IDIX has a strong balance sheet with cash and cash equivalents and short term investments of $104.21 million as of September 7, 2007.

IDIX has been receiving a strong amount of attention the past five trading days and is in a strong uptrend.